The protective role of curcumin in cardiovascular diseases

Kiuchi, 1993, Nematocidal activity of turmeric: synergistic action of curcuminoids, Chem Pharm Bull (Tokyo), 41, 1640, 10.1248/cpb.41.1640

Goel, 2008, Curcumin as “Curecumin”: from kitchen to clinic, Biochem Pharmacol, 75, 787, 10.1016/j.bcp.2007.08.016

Aggarwal, 2003, Anticancer potential of curcumin: preclinical and clinical studies, Anticancer Res, 23, 363

Deodhar, 1980, Preliminary study on antirheumatic activity of curcumin (diferuloyl methane), Indian J Med Res, 71, 632

Satoskar, 1986, Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation, Int J Clin Pharmacol Ther Toxicol, 24, 651

Holt, 2005, Curcumin therapy in inflammatory bowel disease: a pilot study, Dig Dis Sci, 50, 2191, 10.1007/s10620-005-3032-8

Shoskes, 2005, Beneficial effects of the bioflavonoids curcumin and quercetin on early function in cadaveric renal transplantation: a randomized placebo controlled trial, Transplantation, 80, 1556, 10.1097/01.tp.0000183290.64309.21

Durgaprasad, 2005, A pilot study of the antioxidant effect of curcumin in tropical pancreatitis, Indian J Med Res, 122, 315

Ng, 2006, Curry consumption and cognitive function in the elderly, Am J Epidemiol, 164, 898, 10.1093/aje/kwj267

Doroshow, 1991, Doxorubicin-induced cardiac toxicity, N Engl J Med, 324, 843, 10.1056/NEJM199103213241210

Keizer, 1990, Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity, Pharmacol Ther, 47, 219, 10.1016/0163-7258(90)90088-J

Nowak, 1995, Ambroxol inhibits doxorubicin-induced lipid peroxidation in heart of mice, Free Radic Biol Med, 19, 659, 10.1016/0891-5849(95)00028-V

Venkatesan, 1998, Curcumin attenuation of acute adriamycin myocardial toxicity in rats, Br J Pharmacol, 124, 425, 10.1038/sj.bjp.0701877

Daosukho, 2007, Phenylbutyrate, a histone deacetylase inhibitor, protects against adriamycin-induced cardiac injury, Free Radic Biol Med, 42, 1818, 10.1016/j.freeradbiomed.2007.03.007

Marcu, 2006, Curcumin is an inhibitor of p300 histone acetylatransferase, Med Chem, 2, 169, 10.2174/157340606776056133

Farhangkhoee, 2006, Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets, Pharmacol Ther, 111, 384, 10.1016/j.pharmthera.2005.10.008

Stadler, 2003, Increased nitric oxide levels as an early sign of premature aging in diabetes, Free Radic Biol Med, 35, 1240, 10.1016/S0891-5849(03)00499-4

Hattori, 1994, Structure and function of nitric oxide synthases, Int J Cardiol, 47, S71, 10.1016/0167-5273(94)90329-8

Farhangkhoee, 2003, Heme oxygenase in diabetes-induced oxidative stress in the heart, J Mol Cell Cardiol, 35, 1439, 10.1016/j.yjmcc.2003.09.007

Bengmark, 2006, Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases, JPEN J Parenter Enteral Nutr, 30, 45, 10.1177/014860710603000145

Brouet, 1995, Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages, Biochem Biophys Res Commun, 206, 533, 10.1006/bbrc.1995.1076

Farhangkhoee, 2006, Differential effects of curcumin on vasoactive factors in the diabetic rat heart, Nutr Metab (Lond), 3, 27, 10.1186/1743-7075-3-27

Decker, 1977, Altered distribution of lysosomal cathepsin D in ischemic myocardium, J Clin Invest, 59, 911, 10.1172/JCI108713

Mathew, 1982, Changes in glycoproteins in isoproterenol-induced myocardial infarction in rats, Indian J Biochem Biophys, 19, 41

Takahashi, 1990, Collagen degradation in ischaemic rat hearts, Biochem J, 265, 233, 10.1042/bj2650233

Ravichandran, 1991, Influence of isoproterenol-induced myocardial infarction on certain glycohydrolases and cathepsins in rats, Biochem Med Metab Biol, 45, 6, 10.1016/0885-4505(91)90003-4

Srivastava, 1985, Modification of certain inflammation-induced biochemical changes by curcumin, Indian J Med Res, 81, 215

Nirmala, 1996, Protective role of curcumin against isoproterenol induced myocardial infarction in rats, Mol Cell Biochem, 159, 85, 10.1007/BF00420910

Nirmala, 1996, Effect of curcumin on certain lysosomal hydrolases in isoproterenol-induced myocardial infarction in rats, Biochem Pharmacol, 51, 47, 10.1016/0006-2952(95)02118-3

Winter, 1966, Nonsteroid anti-inflammatory agents, Annu Rev Pharmacol, 6, 157, 10.1146/annurev.pa.06.040166.001105

Frey, 2003, Cardiac hypertrophy: the good, the bad, and the ugly, Annu Rev Physiol, 65, 45, 10.1146/annurev.physiol.65.092101.142243

Heineke, 2006, Regulation of cardiac hypertrophy by intracellular signalling pathways, Nat Rev Mol Cell Biol, 7, 589, 10.1038/nrm1983

Sadoshima, 1997, The cellular and molecular response of cardiac myocytes to mechanical stress, Annu Rev Physiol, 59, 551, 10.1146/annurev.physiol.59.1.551

Kolodziejczyk, 1999, MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium, Curr Biol, 9, 1203, 10.1016/S0960-9822(00)80027-5

Paradis, 1996, Serum response factor mediates AP-1-dependent induction of the skeletal alpha-actin promoter in ventricular myocytes, J Biol Chem, 271, 10827, 10.1074/jbc.271.18.10827

Herzig, 1997, Angiotensin II type1a receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overload, Proc Natl Acad Sci U S A, 94, 7543, 10.1073/pnas.94.14.7543

Hasegawa, 1997, cis-Acting sequences that mediate induction of beta-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction, Circulation, 96, 3943, 10.1161/01.CIR.96.11.3943

Backs, 2006, Control of cardiac growth by histone acetylation/deacetylation, Circ Res, 98, 15, 10.1161/01.RES.0000197782.21444.8f

Clayton, 2006, Enhanced histone acetylation and transcription: a dynamic perspective, Mol Cell, 23, 289, 10.1016/j.molcel.2006.06.017

Chan, 2001, p300/CBP proteins: HATs for transcriptional bridges and scaffolds, J Cell Sci, 114, 2363, 10.1242/jcs.114.13.2363

Lill, 1997, Binding and modulation of p53 by p300/CBP coactivators, Nature, 387, 823, 10.1038/42981

Miyamoto, 2006, Histone acetyltransferase activity of p300 is required for the promotion of left ventricular remodeling after myocardial infarction in adult mice in vivo, Circulation, 113, 679, 10.1161/CIRCULATIONAHA.105.585182

Yao, 1998, Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300, Cell, 93, 361, 10.1016/S0092-8674(00)81165-4

Gusterson, 2003, The transcriptional co-activators CREB-binding protein (CBP) and p300 play a critical role in cardiac hypertrophy that is dependent on their histone acetyltransferase activity, J Biol Chem, 278, 6838, 10.1074/jbc.M211762200

Yanazume, 2003, Cardiac p300 is involved in myocyte growth with decompensated heart failure, Mol Cell Biol, 23, 3593, 10.1128/MCB.23.10.3593-3606.2003

Li, 2008, Curcumin prevents and reverses murine cardiac hypertrophy, J Clin Invest, 118, 879

Morimoto, 2008, The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats, J Clin Invest, 118, 868

Yeh, 2005, Inhibition of NFkappaB activation with curcumin attenuates plasma inflammatory cytokines surge and cardiomyocytic apoptosis following cardiac ischemia/reperfusion, J Surg Res, 125, 109, 10.1016/j.jss.2004.11.009

Shishodia, 2007, Modulation of transcription factors by curcumin, Adv Exp Med Biol, 595, 127, 10.1007/978-0-387-46401-5_4

Virani, 2008, Novel markers of inflammation in atherosclerosis, Curr Atheroscler Rep, 10, 164, 10.1007/s11883-008-0024-0

Schoonderwoerd, 2008, New risk factors for atrial fibrillation: causes of ‘not-so-lone atrial fibrillation’, Europace, 10, 668, 10.1093/europace/eun124

Durante, 2003, Heme oxygenase-1 in growth control and its clinical application to vascular disease, J Cell Physiol, 195, 373, 10.1002/jcp.10274

Hancock, 1998, Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes, Nat Med, 4, 1392, 10.1038/3982

Ishikawa, 2001, Heme oxygenase-1 inhibits atherosclerotic lesion formation in ldl-receptor knockout mice, Circ Res, 88, 506, 10.1161/01.RES.88.5.506

Motterlini, 2000, Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress, Free Radic Biol Med, 28, 1303, 10.1016/S0891-5849(00)00294-X

Pae, 2007, Roles of heme oxygenase-1 in curcumin-induced growth inhibition in rat smooth muscle cells, Exp Mol Med, 39, 267, 10.1038/emm.2007.30

Verjovski-Almeida, 1978, Partial reactions in the catalytic and transport cycle of sarcoplasmic reticulum ATPase, Biochemistry, 17, 5006, 10.1021/bi00616a023

Logan-Smith, 2001, Curcumin, a molecule that inhibits the Ca2+-ATPase of sarcoplasmic reticulum but increases the rate of accumulation of Ca2+, J Biol Chem, 276, 46905, 10.1074/jbc.M108778200

Sumbilla, 2002, The slippage of the Ca2+ pump and its control by anions and curcumin in skeletal and cardiac sarcoplasmic reticulum, J Biol Chem, 277, 13900, 10.1074/jbc.M111155200

Duvoix, 2005, Chemopreventive and therapeutic effects of curcumin, Cancer Lett, 223, 181, 10.1016/j.canlet.2004.09.041

Ramirez Bosca, 2000, An hydroalcoholic extract of Curcuma longa lowers the abnormally high values of human-plasma fibrinogen, Mech Ageing Dev, 114, 207, 10.1016/S0047-6374(00)00089-0

Soni, 1992, Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers, Indian J Physiol Pharmacol, 36, 273

Huang, 1992, Inhibitory effect of curcumin, an anti-inflammatory agent, on vascular smooth muscle cell proliferation, Eur J Pharmacol, 221, 381

Cheng, 2001, Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions, Anticancer Res, 21, 2895

Srivastava, 1985, Anti-thrombotic effect of curcumin, Thromb Res, 40, 413, 10.1016/0049-3848(85)90276-2

Phrommintikul, 2006, Roles of cardiac ryanodine receptor in heart failure and sudden cardiac death, Int J Cardiol, 112, 142, 10.1016/j.ijcard.2005.11.106

Coats, 2009, Ethical authorship and publishing, Int J Cardiol, 131, 149, 10.1016/j.ijcard.2008.11.048